<--- Back to Details
First PageDocument Content
Vaccination / Meningococcal disease / Meningococcal vaccine / NmVac4-A/C/Y/W-135 / Neisseria meningitidis / Meningitis / Neisseria / Vaccination schedule / Asplenia / Vaccines / Bacteria / Medicine
Date: 2001-08-06 09:58:06
Vaccination
Meningococcal disease
Meningococcal vaccine
NmVac4-A/C/Y/W-135
Neisseria meningitidis
Meningitis
Neisseria
Vaccination schedule
Asplenia
Vaccines
Bacteria
Medicine

February 14, [removed]Vol[removed]No. RR-5 TM Recommendations and Reports

Add to Reading List

Source URL: www.cdc.gov

Download Document from Source Website

File Size: 274,16 KB

Share Document on Facebook

Similar Documents

New York State Department of Health

New York State Department of Health

DocID: 1rfHH - View Document

John Glenn School Corporation 101 John Glenn Drive, Walkerton, INPhone: (Fax: (www.jgsc.k12.in.us August 1, 2016

John Glenn School Corporation 101 John Glenn Drive, Walkerton, INPhone: (Fax: (www.jgsc.k12.in.us August 1, 2016

DocID: 1r8cN - View Document

Microsoft Word - FINAL_IMD HAN Message_4-2-14

Microsoft Word - FINAL_IMD HAN Message_4-2-14

DocID: 1qoJm - View Document

MENINGOCOCCAL VACCINE NYSDOH has a new page for the Meningococcal Vaccine School Requirement NYSDOH Meningococcal Vaccine Professional Education-The two options below provide an overview of meningitis, vaccines, ACIP rec

MENINGOCOCCAL VACCINE NYSDOH has a new page for the Meningococcal Vaccine School Requirement NYSDOH Meningococcal Vaccine Professional Education-The two options below provide an overview of meningitis, vaccines, ACIP rec

DocID: 1qfUG - View Document

The National Meningitis Association Applauds FDA Approval of First Serogroup B Meningococcal Disease Vaccine October 29, 2014 – Atlanta, GA – The U.S. Food and Drug Administration (FDA) announced today the approval o

The National Meningitis Association Applauds FDA Approval of First Serogroup B Meningococcal Disease Vaccine October 29, 2014 – Atlanta, GA – The U.S. Food and Drug Administration (FDA) announced today the approval o

DocID: 1pndR - View Document